{"id":11486,"date":"2026-09-24T11:03:10","date_gmt":"2026-09-24T09:03:10","guid":{"rendered":"https:\/\/www.adacyte.com\/?p=11486"},"modified":"2026-09-24T11:10:16","modified_gmt":"2026-09-24T09:10:16","slug":"enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares","status":"publish","type":"post","link":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/","title":{"rendered":"Enfermedad inflamatoria intestinal (EII) y problemas oculares"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><\/h3>\n<\/div>\n\n<div class=\"wp-block-image\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\" alt=\"\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><br><u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/evinature.com\/crohns-and-colitis\/&amp;sa=D&amp;source=editors&amp;ust=1790242499232907&amp;usg=AOvVaw0dC1bM5PLnV2BJOi8GRK4N\">La enfermedad inflamatoria intestinal (EII)<\/a><\/u>\u00a0es una enfermedad cr\u00f3nica que afecta principalmente al tracto gastrointestinal. La EII se caracteriza por la inflamaci\u00f3n de la pared intestinal, pero su impacto no se limita al intestino; al contrario, se asocia con un amplio espectro de manifestaciones extraintestinales (MEI) que afectan a diversos \u00f3rganos y sistemas, como la piel, el sistema musculoesquel\u00e9tico, el sistema hepatobiliar y, no menos importante, los ojos. En el contexto de los <em>ojos<\/em>, la EII puede manifestarse a trav\u00e9s de diversas <strong>complicaciones oculares<\/strong>\u00a0including inflammation and irritation. These eye-related issues often arise due to the systemic inflammation that characterizes IBD, potentially leading to conditions such as <em>uve\u00edtis, epiescleritis y escleritis<\/em>.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>La detecci\u00f3n y el tratamiento precoces son fundamentales, ya que estas afecciones oculares pueden afectar de forma significativa a la visi\u00f3n y a la calidad de vida.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><strong>1.- \u00bfPueden la enfermedad de Crohn y\/o la colitis ulcerosa causar problemas oculares?<\/strong><\/h3>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>S\u00ed, tanto la&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/evinature.com\/blog\/gut-health\/ibd-symptoms-causes-diagnosis-and-treatment\/&amp;sa=D&amp;source=editors&amp;ust=1790242499234106&amp;usg=AOvVaw0qz6PgXOjXsaiEBB9gNcuQ\">enfermedad de Crohn como la colitis ulcerosa<\/a><\/u>, los dos principales tipos de enfermedad inflamatoria intestinal (EII), pueden causar problemas oculares. Las complicaciones oculares son relativamente frecuentes, y algunos estudios sugieren que <strong>hasta el 10 % de las personas<\/strong>&nbsp;with IBD experience some form of eye involvement (ocular EIMs (O-EIMs)) throughout the course of the disease.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>El&nbsp; <u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/evinature.com\/blog\/gut-health\/crohns-colitis-and-eye-problems\/The%2520Gut-Brain%2520Connection&amp;sa=D&amp;source=editors&amp;ust=1790242499234591&amp;usg=AOvVaw3vjOc7qKCW4ArV7CvRJHnz\">eje intestino-cerebro<\/a><\/u>,<\/strong>&nbsp;un sistema de comunicaci\u00f3n bidireccional entre el tracto gastrointestinal y el sistema nervioso central, desempe\u00f1a un papel importante en los trastornos gastrointestinales funcionales. La disfunci\u00f3n de este eje puede influir en la salud ocular mediante mecanismos relacionados con el estr\u00e9s, la inflamaci\u00f3n y la alteraci\u00f3n de la se\u00f1alizaci\u00f3n del sistema nervioso.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Estr\u00e9s y problemas oculares<\/strong>:&nbsp;<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/evinature.com\/blog\/gut-health\/stress-ibd-new-research-on-the-connection\/&amp;sa=D&amp;source=editors&amp;ust=1790242499235096&amp;usg=AOvVaw0gcaCcMcECH2FFETFlcHNO\">El estr\u00e9s cr\u00f3nico<\/a><\/u>, frecuente en pacientes con trastornos gastrointestinales debido a la naturaleza impredecible de sus s\u00edntomas, puede agravar afecciones como el <em>s\u00edndrome del ojo seco.<\/em>&nbsp;Una investigaci\u00f3n publicada en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.nature.com\/articles\/nrgastro.2016.142&amp;sa=D&amp;source=editors&amp;ust=1790242499235391&amp;usg=AOvVaw2DswPqY6uznTG4ObzYNHZO\">Nature Reviews Gastroenterology &amp; Hepatology<\/a><\/u>&nbsp;indica que el estr\u00e9s cr\u00f3nico afecta a la producci\u00f3n de l\u00e1grimas y a la estabilidad de la superficie ocular, aumentando el riesgo de <em>ojo seco<\/em>&nbsp;y otras afecciones oculares.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Implicaci\u00f3n neurol\u00f3gica (sistema nervioso aut\u00f3nomo, SNA)<\/strong>:<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Algunos&nbsp;trastornos gastrointestinales se asocian con alteraciones en el funcionamiento del sistema nervioso aut\u00f3nomo, lo que puede afectar a la salud ocular. Los estudios han demostrado que la desregulaci\u00f3n del sistema nervioso aut\u00f3nomo, que controla funciones involuntarias como la secreci\u00f3n lagrimal, puede provocar problemas como <em>ojo seco y enfermedad de la superficie ocular<\/em>. Un estudio publicado en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4362231\/&amp;sa=D&amp;source=editors&amp;ust=1790242499236044&amp;usg=AOvVaw1Fz1jghYA5PrbDTDt83Zt9\">Gastroenterology<\/a><\/u>&nbsp;analiza esta relaci\u00f3n y destaca c\u00f3mo la disfunci\u00f3n del sistema nervioso aut\u00f3nomo afecta a diversos sistemas org\u00e1nicos, incluidos los ojos.<\/p>\n<\/div>\n\n<div class=\"wp-block-image\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image5.jpg\" alt=\"\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><strong>2.- \u00bfQu\u00e9 problemas oculares causa la enfermedad de Crohn?<\/strong><\/h3>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Los problemas oculares frecuentes asociados con la <em>enfermedad de Crohn<\/em>&nbsp;incluyen <em>epiescleritis, uve\u00edtis, escleritis, queratopat\u00eda y s\u00edndrome del ojo seco. <\/em><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Estas afecciones oculares pueden aparecer no solo por la desregulaci\u00f3n inmunitaria asociada a la enfermedad de Crohn, sino tambi\u00e9n como efectos adversos de tratamientos como los corticosteroides, los inmunosupresores y los f\u00e1rmacos biol\u00f3gicos, que pueden agravar o contribuir a las complicaciones oculares.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Tanto la propia enfermedad como los medicamentos utilizados para tratarla desempe\u00f1an un papel importante en el desarrollo y la gravedad de estos problemas oculares.<\/p>\n<\/div>\n\n<div class=\"wp-block-image\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image4.png\" alt=\"\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Uve\u00edtis<\/strong><\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>La uve\u00edtis es la inflamaci\u00f3n de la \u00favea, la capa media del ojo, que incluye el iris, el cuerpo ciliar y la coroides. Esta afecci\u00f3n puede causar enrojecimiento, dolor, sensibilidad a la luz y, potencialmente, <em>provocar p\u00e9rdida de visi\u00f3n<\/em>&nbsp;si no se trata. A menudo est\u00e1&nbsp;relacionada con la respuesta autoinmunitaria subyacente que impulsa la enfermedad.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>El sistema inmunitario, que ya presenta una actividad excesiva en la enfermedad de Crohn, puede atacar por error los tejidos del ojo. Seg\u00fan una investigaci\u00f3n publicada en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5583569\/&amp;sa=D&amp;source=editors&amp;ust=1790242499237581&amp;usg=AOvVaw2HPGEpbLGfda-vESIzJQpR\">The National Library of Medicine<\/a><\/u>, <em>uve\u00edtis <\/em>puede ser en ocasiones el <em>primer signo de la enfermedad de Crohn<\/em>, incluso antes de que aparezcan los s\u00edntomas gastrointestinales.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Epiescleritis<\/strong><\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>La epiescleritis es la inflamaci\u00f3n de la epiesclera, la fina capa de tejido que recubre la parte blanca del ojo. Esta afecci\u00f3n suele ser leve y causa enrojecimiento y molestias sin provocar alteraciones graves de la visi\u00f3n.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>A menudo se asocia con brotes activos de la enfermedad. Una investigaci\u00f3n publicada en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7043099\/&amp;sa=D&amp;source=editors&amp;ust=1790242499238201&amp;usg=AOvVaw1TJlfdcxjvU6KkAhxJVCTe\">Gastroenterology<\/a><\/u>&nbsp;sugiere que esta inflamaci\u00f3n puede estar provocada por los mismos mecanismos inmunitarios que causan la inflamaci\u00f3n intestinal en la enfermedad de Crohn.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Escleritis<\/strong><\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>La escleritis implica una inflamaci\u00f3n m\u00e1s profunda y grave de la escler\u00f3tica, la capa externa blanca del ojo. Esta afecci\u00f3n es dolorosa y puede provocar complicaciones <em>como la p\u00e9rdida de visi\u00f3n<\/em>&nbsp;si no se trata adecuadamente.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Se considera que la escleritis en la enfermedad de Crohn se debe al car\u00e1cter sist\u00e9mico de la inflamaci\u00f3n y, posiblemente, al uso de determinados medicamentos, como los <em>inhibidores del TNF<\/em>, que se utilizan para tratar la enfermedad de Crohn pero se han relacionado con respuestas inflamatorias parad\u00f3jicas. Estudios publicados en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10455403\/&amp;sa=D&amp;source=editors&amp;ust=1790242499238966&amp;usg=AOvVaw246rmpDHTxgKJKQb6xdeHA\">The American Journal of Gastroenterology<\/a><\/u>&nbsp;han destacado la importancia de abordar r\u00e1pidamente la escleritis en pacientes con EII para prevenir da\u00f1os a largo plazo.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>S\u00edndrome del ojo seco<\/strong><\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>El s\u00edndrome del ojo seco aparece cuando los ojos no producen suficientes l\u00e1grimas o estas se evaporan demasiado r\u00e1pido, lo que provoca sequedad, irritaci\u00f3n, sensaci\u00f3n de arenilla y molestias persistentes. La enfermedad de Crohn puede causar s\u00edndrome del ojo seco debido a la inflamaci\u00f3n que puede afectar a las gl\u00e1ndulas responsables de la producci\u00f3n de l\u00e1grimas.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Adem\u00e1s, determinados medicamentos utilizados para tratar la enfermedad de Crohn, como los corticosteroides, pueden reducir la producci\u00f3n de l\u00e1grimas. Estudios publicados en&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10576268\/&amp;sa=D&amp;source=editors&amp;ust=1790242499239670&amp;usg=AOvVaw3MUomyvXai6KZKylx5NDwZ\">Ophthalmology<\/a><\/u>&nbsp;han demostrado que los pacientes con enfermedad de Crohn presentan un mayor riesgo de desarrollar s\u00edndrome del ojo seco, especialmente cuando la enfermedad est\u00e1 activa.<\/p>\n<\/div>\n\n<div class=\"wp-block-image\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image7.jpg\" alt=\"\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li><strong>Queratopat\u00eda<\/strong><\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>La queratopat\u00eda engloba un conjunto de afecciones que afectan a la c\u00f3rnea y que suelen caracterizarse por visi\u00f3n borrosa, dolor ocular, enrojecimiento y sensibilidad a la luz. Seg\u00fan el&nbsp;<u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9542356\/&amp;sa=D&amp;source=editors&amp;ust=1790242499240275&amp;usg=AOvVaw0GXsEvlOZwLF3UM5JDPVPO\">Journal of Ophthalmology<\/a><\/u>&nbsp;en los casos graves, la ulceraci\u00f3n corneal puede provocar una importante <em>discapacidad visual<\/em>.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>En el contexto de la enfermedad inflamatoria intestinal (EII), la queratopat\u00eda es menos frecuente, pero puede aparecer debido a la inflamaci\u00f3n sist\u00e9mica o como efecto secundario de los medicamentos utilizados para controlar la EII, como los corticosteroides.&nbsp;<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/pubmed.ncbi.nlm.nih.gov\/38247834\/&amp;sa=D&amp;source=editors&amp;ust=1790242499240718&amp;usg=AOvVaw2yhKOLPVgtnwgOn2CzJZra\">Los estudios<\/a><\/u>&nbsp;han demostrado que la inflamaci\u00f3n sist\u00e9mica en la EII puede agravar las enfermedades de la superficie ocular, incluida la queratopat\u00eda, debido al da\u00f1o del tejido corneal mediado por el sistema inmunitario.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><strong>3.- Productos naturales y problemas oculares: recomendaciones<\/strong><\/h3>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Un manejo adecuado de la salud intestinal y del estr\u00e9s puede mejorar significativamente los problemas oculares asociados a la EII al reducir la inflamaci\u00f3n sist\u00e9mica. Mantener un microbioma intestinal equilibrado y controlar los niveles de estr\u00e9s puede ayudar a aliviar tanto los s\u00edntomas gastrointestinales como los oculares, favoreciendo una mejor salud y bienestar general.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Determinados suplementos pueden ser beneficiosos para las personas con EII que presentan problemas oculares relacionados con la enfermedad y niveles elevados de estr\u00e9s. Por ejemplo, la <em>curcumina<\/em>&nbsp;se recomienda para favorecer la salud intestinal o ayudar a mantener el equilibrio intestinal. La <em>coptis<\/em>&nbsp;tambi\u00e9n puede utilizarse con estos fines. La <em>ashwagandha, la manzanilla o la corteza de mimosa<\/em>&nbsp;pueden ayudar a controlar el estr\u00e9s, entre otros usos.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Todo ello puede ayudar a reducir la inflamaci\u00f3n sist\u00e9mica y, por tanto, los s\u00edntomas de la EII, como las manifestaciones oculares.<\/p>\n<\/div>\n\n<div class=\"wp-block-image\"><div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image6.jpg\" alt=\"\"\/><\/figure>\n<\/div><\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><strong>4.- Consejos para cuidar la salud ocular en pacientes con EII <\/strong><\/h3>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>A continuaci\u00f3n se ofrecen algunos consejos y recomendaciones para ayudar a mantener la salud ocular y abordar posibles problemas de forma precoz:<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li>Protege los ojos de los factores ambientales que puedan irritarlos.<\/li>\n\n\n\n<li>Sigue correctamente el tratamiento prescrito y consulta con tu especialista cualquier posible efecto secundario.<\/li>\n\n\n\n<li>Mant\u00e9n bajo control la inflamaci\u00f3n sist\u00e9mica.<\/li>\n\n\n\n<li>Mantente informado y participa activamente en el manejo de tu enfermedad.<\/li>\n\n\n\n<li>Presta atenci\u00f3n a cualquier nuevo s\u00edntoma ocular. Consulta a un oftalm\u00f3logo cuando sea necesario.<\/li>\n\n\n\n<li>Realiza revisiones oftalmol\u00f3gicas peri\u00f3dicas.<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h3 class=\"wp-block-heading\"><strong>Referencias:<\/strong><\/h3>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li>In, J., Foulke-Abel, J., Estes, M.&nbsp;<em>et al.<\/em>&nbsp;Human mini-guts: new insights into intestinal physiology and host\u2013pathogen interactions.&nbsp;<em>Nat Rev Gastroenterol Hepatol<\/em>&nbsp;13, 633\u2013642 (2016). <u><a href=\"https:\/\/www.google.com\/url?q=https:\/\/doi.org\/10.1038\/nrgastro.2016.142&amp;sa=D&amp;source=editors&amp;ust=1790242499242989&amp;usg=AOvVaw3qobFlbSOv3HXOnwZRZqqQ\">https:\/\/doi.org\/10.1038\/nrgastro.2016.142<\/a><\/u><\/li>\n\n\n\n<li>Mayer EA, Tillisch K, Gupta A. Gut\/brain axis and the microbiota. J Clin Invest. 2015 Mar 2;125(3):926-38. doi: 10.1172\/JCI76304. Epub 2015 Feb 17.<\/li>\n\n\n\n<li>Imam L, Haboubi HN. G-Eye: ocular manifestations of gastrointestinal disease. Frontline Gastroenterol. 2019 Mar 8;11(2):162-167. doi: 10.1136\/flgastro-2018-101083.<\/li>\n\n\n\n<li>Pytrus W, Akutko K, Pytrus T, Turno-Kr\u0119cicka A. A Review of Ophthalmic Complications in Inflammatory Bowel Diseases. J Clin Med. 2022 Dec 15;11(24):7457. doi: 10.3390\/jcm11247457.<\/li>\n\n\n\n<li>Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol. 2017 Aug 28;23(32):5836-5848. doi: 10.3748\/wjg.v23.i32.5836.<\/li>\n\n\n\n<li>Migliorisi G, Vella G, Dal Buono A, Gabbiadini R, Busacca A, Loy L, Bezzio C, Vinciguerra P, Armuzzi A. Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It. Cells. 2024 Jan 12;13(2):142. doi: 10.3390\/cells13020142.<\/li>\n\n\n\n<li>Mihai IR, Burlui AM, Rezus II, Mihai C, Macovei LA, Cardoneanu A, Gavrilescu O, Dranga M, Rezus E. Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-\u03b1 Treatment-A Review. Life (Basel). 2023 Aug 20;13(8):1779. doi: 10.3390\/life13081779.<\/li>\n\n\n\n<li>Cabrera-Aguas M, Khoo P, Watson SL. Infectious keratitis: A review. Clin Exp Ophthalmol. 2022 Jul;50(5):543-562. doi: 10.1111\/ceo.14113. Epub 2022 Jun 3.<\/li>\n\n\n\n<li>Ko YT, Wu YM, Wu HL, Lai SC, Dai YX, Chen TJ, Cherng YG, Tai YH, Kao CY. Inflammatory bowel disease and the associated risk of ojo seco and ocular surface injury: a nationwide matched cohort study. BMC Ophthalmol. 2023 Oct 13;23(1):415. doi: 10.1186\/s12886-023-03165-z.<\/li>\n<\/ul>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>La enfermedad inflamatoria intestinal (EII)\u00a0es una enfermedad cr\u00f3nica que afecta principalmente al tracto gastrointestinal. La EII se caracteriza por la inflamaci\u00f3n de la pared intestinal, pero su impacto no se limita al intestino; al contrario, se asocia con un amplio espectro de manifestaciones extraintestinales (MEI) que afectan a diversos \u00f3rganos y sistemas, como la piel, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":11500,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[],"class_list":["post-11486","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novedades-es"],"acf":{"h_removemb":false,"imgs":{"img_desktop":11520,"img_mobile":11500},"text_above_title":"","description":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte<\/title>\n<meta name=\"description\" content=\"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-24T09:03:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T09:10:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1062\" \/>\n\t<meta property=\"og:image:height\" content=\"732\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Adacyte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adacyte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\"},\"author\":{\"name\":\"Adacyte\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\"},\"headline\":\"Enfermedad inflamatoria intestinal (EII) y problemas oculares\",\"datePublished\":\"2026-09-24T09:03:10+00:00\",\"dateModified\":\"2026-09-24T09:10:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\"},\"wordCount\":1683,\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\",\"articleSection\":[\"Novedades\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\",\"url\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\",\"name\":\"Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\",\"datePublished\":\"2026-09-24T09:03:10+00:00\",\"dateModified\":\"2026-09-24T09:10:16+00:00\",\"description\":\"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg\",\"width\":1062,\"height\":732},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\",\"name\":\"Adacyte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"caption\":\"Adacyte\"},\"url\":\"https:\/\/www.adacyte.com\/es\/author\/adacyte\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte","description":"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/","og_locale":"es_ES","og_type":"article","og_title":"Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte","og_description":"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.","og_url":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/","og_site_name":"Adacyte","article_published_time":"2026-09-24T09:03:10+00:00","article_modified_time":"2026-09-24T09:10:16+00:00","og_image":[{"width":1062,"height":732,"url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg","type":"image\/jpeg"}],"author":"Adacyte","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Adacyte","Tiempo de lectura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#article","isPartOf":{"@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/"},"author":{"name":"Adacyte","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f"},"headline":"Enfermedad inflamatoria intestinal (EII) y problemas oculares","datePublished":"2026-09-24T09:03:10+00:00","dateModified":"2026-09-24T09:10:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/"},"wordCount":1683,"publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"image":{"@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg","articleSection":["Novedades"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/","url":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/","name":"Enfermedad inflamatoria intestinal (EII) y problemas oculares - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage"},"image":{"@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg","datePublished":"2026-09-24T09:03:10+00:00","dateModified":"2026-09-24T09:10:16+00:00","description":"Inflammatory Bowel Disease (IBD), including both Crohn\u2019s disease and ulcerative colitis, can prevent us frommaintaining an exercise routine due to the symptoms it causes: abdominal pain, fatigue, or diarrhea makenormal body movement difficult, leading many patients to avoid any type of training.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/es\/enfermedad-inflamatoria-intestinal-eii-y-problemas-oculares\/#primaryimage","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2026\/08\/image3.jpg","width":1062,"height":732},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f","name":"Adacyte","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","caption":"Adacyte"},"url":"https:\/\/www.adacyte.com\/es\/author\/adacyte\/"}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/posts\/11486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/comments?post=11486"}],"version-history":[{"count":0,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/posts\/11486\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media\/11500"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=11486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/categories?post=11486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/tags?post=11486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}